Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |Streptavidin（SA） Hot |Claudin 18.2 |Cadherin-17 
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > TROP2

TROP2

Brief Information

Name:Tumor-associated calcium signal transducer 2
Target Synonym:Tumor-associated calcium signal transducer 2,M1S1,TROP2,TACSTD2,Pancreatic carcinoma marker protein GA733-1,Tumor Associated Calcium Signal Transducer 2,GA733-1,Membrane Component, Chromosome 1, Surface Marker 1,Gastrointestinal Tumor-Associated Antigen GA7331,Pancreatic Carcinoma Marker Protein GA7331,Cell surface glycoprotein Trop-2,Membrane component chromosome 1 surface marker 1,40kD Glycoprotein, Identified By Monoclonal Antibody GA733,Cell Surface Glycoprotein TROP2,Epithelial Glycoprotein
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:19
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CEA-B032 Human ClinMax™ Human Soluble TROP2 ELISA Kit, PRO
HCS-S311 Mouse Recombinant Monoclonal Anti-TROP2 Antibody, Mouse (3A8)
HCS-S310 Mouse Recombinant Monoclonal Anti-TROP2 Antibody, Mouse (2A9)
ACRO Quality

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Sacituzumab govitecan IMMU0132; GS-0132; IMMU-0132; IMMU-132; TROP-2-SN-38 Approved Immunomedics Inc, Gilead Sciences Inc Trodelvy, 拓达维, TRODELVY United States Triple Negative Breast Neoplasms Immunomedics Inc 2020-04-22 Brain metastases; Urinary Bladder Neoplasms; Klatskin Tumor; Breast Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Bile Duct Neoplasms; Metastatic breast cancer; Esophageal Squamous Cell Carcinoma; Thyroid Carcinoma, Anaplastic; Endometrial Neoplasms; Thymoma; Thyroid Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Solid tumours; Neoplasms; Salivary Gland Neoplasms; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Ovarian Epithelial; Glioblastoma; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Stomach Neoplasms; Biliary Tract Neoplasms; Ovarian Neoplasms; Liver Failure Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
SHR-A1921 SHR-A1921; SHRA1921; SHR-1921 Phase 3 Clinical Suzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd Solid tumours; Ovarian Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Salivary Gland Neoplasms; Breast Neoplasms; Brain metastases Details
OBI-992 OBI-992 Phase 2 Clinical Obi Pharma Usa Inc Solid tumours; Stomach Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Non-Small-Cell Lung Details
HS-20105 HS-20105; HS20105 Phase 2 Clinical Hansoh BioMedical R&D Company Solid tumours Details
IBI130 IBI130; IBI-130 Phase 2 Clinical Innovent Biologics(Suzhou) Co Ltd Solid tumours; Neoplasm Metastasis Details
Anti TROP2 antibody drug conjugate ADC（Fudan University） Phase 2 Clinical Fudan University Triple Negative Breast Neoplasms Details
9MW-2921 9MW2921; 9MW-2921 Phase 2 Clinical Mabwell (Shanghai) Bioscience Co Ltd Solid tumours Details
MHB036C MHB-036C Phase 2 Clinical Minghui Pharmaceutical Pty Ltd Solid tumours Details
BAT-8008 BAT8008; BAT-8008 Phase 2 Clinical Bio-Thera Solutions Ltd Solid tumours Details
DB-1305 DB1305; BNT325; DB-1305; BNT-325 Phase 2 Clinical Duality Biologics Co Ltd Solid tumours Details
BIO-106 BIO-106 Phase 2 Clinical Hangzhou Baikai Biopharmaceutical Co Ltd Solid tumours; Neoplasms Details
BL-M02D1 Phase 2 Clinical Baili-Bio (Chengdu) Pharmaceutical Co Ltd, Sichuan Baili Pharmaceutical Co Ltd Solid tumours; Triple Negative Breast Neoplasms; Digestive System Neoplasms; Breast Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
LCB-84 LCB-84 Phase 2 Clinical Legochem Biosciences Inc Solid tumours Details
重组人源化抗Trop2单抗-SN38偶联物 ESG-401; STI-3258 Phase 2 Clinical Shanghai Escugen Biotechnology Co Ltd, Tot Biopharm Co Ltd Solid tumours; Ovarian Neoplasms; Stomach Neoplasms; Neoplasms; Urinary Bladder Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms Details
FDA018 Antibody Drug Conjugate FDA018-ADC; FDA-018-ADC Phase 2 Clinical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Solid tumours; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Neoplasm Metastasis Details
DAC-002 DAC-002; JS-108 Phase 1 Clinical Hangzhou Dac Biotech Company Ltd Solid tumours; Triple Negative Breast Neoplasms; Small Cell Lung Carcinoma Details
MT-302 MT-302 Phase 1 Clinical Myeloid Therapeutics Inc Carcinoma; Colonic Neoplasms; Breast Neoplasms; Lung Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap